Laurus Labs Ltd. (LAURUSLABS): Laurus Labs Share Price hits fresh 52-week high; stock slips 0.29% from the peak

Published: 27 August 2026 at 9:29 AM IST

Laurus Labs Share Price hit a fresh 52-week high of Rs 1,903 and later closed at Rs 1,882.45, down 0.29% on the day. The company’s market capitalisation stood at Rs 1,00,768.23 crore.

Laurus Labs Share Price is in focus after the stock touched a fresh 52-week high of Rs 1,903 and then closed at Rs 1,882.45. The move left the stock Rs 5.55 lower than the previous close of Rs 1,888, while the day’s range remained tight between Rs 1,878.25 and Rs 1,903. The company’s market capitalisation was Rs 1,00,768.23 crore, placing Laurus Labs among the larger healthcare names by market value. In Univest coverage, this is a clear fresh 52-week-high event, not an all-time high claim. The supplied data confirms the price event, but it does not establish a company-specific catalyst. For readers tracking Laurus Labs Share Price Today, the key context is the new yearly peak, the marginally negative close and the valuation backdrop that follows.

The stock news flow around Laurus Labs Share Price therefore centres on verified price action and measurable fundamentals. The current print, market capitalisation, sector classification and benchmark comparisons together explain why Laurus Labs Stock News is drawing attention in Stock Market Today screens. Investors using Univest can place the move alongside Laurus Labs Share Price Live checks, Laurus Labs News Today and Laurus Labs Share Price Update searches without relying on unsupported assumptions about the day’s trigger.

Laurus Labs Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 1,882.45
Previous Close	Rs 1,888
Today's Move	Rs -5.55 (-0.29%)
Open	Rs 1,888.05
High	Rs 1,903
Low	Rs 1,878.25
Turnover	Rs 3.2 crore
Market Capitalisation	Rs 1,00,768.23 crore

Laurus Labs Ltd. (LAURUSLABS) traded at Rs 1,882.45 versus the previous close of Rs 1,888, a fall of 0.29%. The stock opened at Rs 1,888.05, reached a high of Rs 1,903 and touched a low of Rs 1,878.25.

Laurus Labs Share Price Today reflects a session that opened at Rs 1,888.05, moved as high as Rs 1,903 and as low as Rs 1,878.25, and finally settled at Rs 1,882.45. The stock was down Rs 5.55, or 0.29%, versus the previous close of Rs 1,888. The fresh 52-week high of Rs 1,903 was also the day’s high, which means the yearly high and the session peak were the same print.

That combination is useful for anyone scanning Laurus Labs Share Price News because it shows that the market data recorded a one-year high even though the close finished slightly below the prior day’s level. The move is also relevant for Laurus Labs Share Price Today searches since the stock remains near the top of its recent range. Turnover stood at Rs 3.2 crore, which is the factual traded-value metric supplied for the session. On a simple arithmetic basis, the stock closed Rs 20.55 below the day’s high and Rs 1.55 above the day’s low. For readers following Laurus Labs Stock News, this is the verified day structure that matters most.

In Univest’s editorial format, the next step is to read this price action alongside the company’s disclosed valuation and operating metrics, because the fresh 52-week high is meaningful only when viewed with the underlying fundamentals.

Laurus Labs Ltd. (LAURUSLABS) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 1,00,768.23 crore
P/E Ratio	93.3x
P/B Ratio	18.09x
ROE	18.31%
ROCE	18.2%
EPS	Rs 20.24
Book Value Per Share	Rs 104.37
Dividend Yield	0.11%

Laurus Labs Ltd. (LAURUSLABS) fundamental metrics show P/E 93.3x, P/B 18.09x, ROE 18.31%, ROCE 18.2%. These figures provide context only and are not a buy or sell signal.

Laurus Labs Ltd. has a market capitalisation of Rs 100768.23 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 93.3x, P/B at 18.09x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 18.31% and ROCE of 18.2%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 20.24, book value per share of Rs 104.37, dividend yield of 0.11%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 30.54x, median ROE of 11.83%, median ROCE of 13.75%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	93.3x
Benchmark Median P/E	30.54x
Benchmark Average P/E	46.89x
Benchmark P/E Range	3.19x to 671.51x
Company P/B Ratio	18.09x
Benchmark Median P/B	2.76x
Company ROE	18.31%
Benchmark Median ROE	11.83%
Company ROCE	18.2%
Benchmark Median ROCE	13.75%
Company Market Capitalisation	Rs 1,00,768.23 crore
Benchmark Median Market Cap	Rs 623.8 crore

Laurus Labs Ltd. (LAURUSLABS) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Laurus Labs Ltd. (LAURUSLABS) has a P/E ratio of 93.3x, which is above the benchmark median of 30.54x, a difference of +205.5%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Laurus Labs Ltd. (LAURUSLABS) has a ROE of 18.31%, which is above the benchmark median of 11.83%, a difference of +54.78%. Laurus Labs Ltd. (LAURUSLABS) has a ROCE of 18.2%, which is above the benchmark median of 13.75%, a difference of +32.36%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Lupin Ltd.	LUPIN	99,448.59	18.12	4.21	27.11	28.86
Dr. Reddy's Laboratories Ltd.	DRREDDY	99,409.89	30.73	2.59	11.69	13.75
Mankind Pharma Ltd.	MANKIND	97,756.15	48.38	5.87	12.69	13.24
Aurobindo Pharma Ltd.	AUROPHARMA	92,247.46	25.14	2.4	9.93	12.76
Zydus Lifesciences Ltd.	ZYDUSLIFE	1,12,717.93	25.37	4.25	19.69	21.39

Laurus Labs Ltd. (LAURUSLABS) has a P/E ratio of 93.3x compared with the displayed peer median of 25.37x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 18.31% compares with a peer median of 12.69% across the companies shown in the table. ROCE stood at 18.2% versus the displayed peer median of 13.75%, providing a capital-efficiency comparison. Laurus Labs Ltd. (LAURUSLABS) has a market capitalisation of Rs 1,00,768.23 crore. Among the 5 peers shown, 1 has a larger market capitalisation.

Why Investors Are Watching Laurus Labs

• Laurus Labs Share Price touched a fresh 52-week high of Rs 1,903 and closed at Rs 1,882.45.
• The day’s change was -0.29%, with the previous close at Rs 1,888 and the open at Rs 1,888.05.
• The company’s market capitalisation stood at Rs 1,00,768.23 crore.
• P/E was 93.3 and P/B was 18.09, both above the supplied healthcare benchmark median.
• ROE was 18.31% and ROCE was 18.2%, both above the supplied same-industry median.

About Laurus Labs

Laurus Labs Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied company profile places Laurus Labs Share Price in a listed pharmaceutical context, with financial data showing revenue and profit figures for the latest reported periods. Univest tracks Laurus Labs Stock News, Laurus Labs Company News and Laurus Labs Latest News alongside the stock’s market update so readers can connect the price event with the reported financial record.

Track Laurus Labs Share Price on Univest

Use Laurus Labs Ltd. (LAURUSLABS) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Readers can track Laurus Labs Share Price on Univest for live price updates, share price news, market capitalisation, fundamental ratios, shareholding pattern, 52-week levels and market insights. Univest also presents Laurus Labs Share Price Today, Laurus Labs Stock Analysis and Laurus Labs Financial Analysis in a format designed for quick reading and deeper review.

Frequently Asked Questions

Why did Laurus Labs Share Price hit a fresh 52-week high?

Ans. Laurus Labs Share Price touched Rs 1,903, which is the supplied fresh 52-week high. The data confirms the price event, but it does not establish a company-specific catalyst for the move.

What was Laurus Labs Share Price today?

Ans. Laurus Labs Share Price closed at Rs 1,882.45, down 0.29% from the previous close of Rs 1,888. The session also recorded a high of Rs 1,903 and a low of Rs 1,878.25.

Is the 52-week high also the day’s high for Laurus Labs?

Ans. Yes. The supplied day high and 52-week high are both Rs 1,903. That makes the yearly peak and the session high the same price print in this event. The stock moved -0.29% during the session.

What is Laurus Labs market cap?

Ans. Laurus Labs has a market capitalisation of Rs 1,00,768.23 crore. That is much higher than the supplied same-industry median of Rs 623.8 crore and helps frame the stock’s size within healthcare.

How expensive is Laurus Labs Share Price on the supplied P/E?

Ans. The P/E ratio is 93.3, which is above the healthcare benchmark median of 30.54 and average of 46.89. The supplied comparison shows a premium valuation against the same-industry set. The stock moved -0.29% during the session.

What does Laurus Labs ROE and ROCE show?

Ans. ROE is 18.31% and ROCE is 18.2%. Both are above the supplied sector medians, which places the return ratios above the benchmark middle point in the same-industry comparison. ROE stands at 18.31%.

What are Laurus Labs EPS, book value and dividend yield?

Ans. EPS is Rs 20.24, book value is Rs 104.37 and dividend yield is 0.11%. These are the exact supplied fundamentals and they help readers assess earnings, accounting value and payout context.

How does Laurus Labs compare with pharma peers?

Ans. Laurus Labs has a higher P/E than Lupin, Dr. Reddy’s, Mankind Pharma, Aurobindo Pharma and Zydus Lifesciences in the supplied peer set. Its ROE and ROCE are above several peers, but not all.

Which sector and industry does Laurus Labs belong to?

Ans. Laurus Labs belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. The supplied benchmark comparison is built on the same-industry set, so this is the relevant context for the stock.

What should readers watch next in Laurus Labs Share Price news?

Ans. Readers should watch whether the stock sustains trade near the fresh 52-week high, how the valuation compares with peers, and whether future reported revenue and profit figures continue to support the current price level.